Polypeptide Consisting Of A Glucagon-Like Peptide-1 Receptor Agonist And An Amylin Receptor Agonist, Connected By A Linker With 4 Glycine Residues, And Connected To A C18 Fatty Acid Side Chain

1 trials

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

9 Countries

Phase II

Phase II: 1

Sponsors using this IMP

Novo Nordisk A/S 1

All trials

1 total

A research study comparing how well different doses of the medicine NNC0487-0111 lower blood sugar in people with type 2 diabetes Ended

2023-509412-28-00 Phase II 9 countries Novo Nordisk A/S

Showing 1–1 of 1 trials

← All drugs A–Z